Form 4 for RANI Rani Therapeutics Holdings, Inc.
Accepted 2022-11-07 00:00:00 ET · period of report 2022-11-03 · accession 0001104659-22-115484 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-11-07 | 2022-11-03 | RANI | Quiroga Cortes Isidoro Alfonso | 10% | P - Purchase | $6.90 | +15.2K | 5.26M | +0.3% | +$104.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-11-03 | P | A | 15,192 | $6.90 | 5,262,978 | I Shares indirectly held through Aequanimitas Limited Partnership | — | — | (F1) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.42 to $7.00 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. (F2) Isidoro Alfonso Quiroga Cortes directly owns 100% of the issued and outstanding interest of the Aequanimitas Management LLC (the "General Partner"). The General Partner directly controls Aequanimitas Limited Partnership ("Aequanimitas") as its general partner with the power to manage Aequanimitas. Quiroga Cortes is the sole limited partner of Aequanimitas. |